Dietary Fat and Endothelial Function in Type 1 Diabetes
NCT ID: NCT04812782
Last Updated: 2021-03-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
16 participants
INTERVENTIONAL
2018-02-12
2019-10-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Impact of Fitness on Vascular Dysfunction in Adolescents With Type 1 Diabetes
NCT01337947
Involvement of Extrapancreatic Factors on Gastrointestinal-mediated Glucose Disposal
NCT02006459
Effects of Vitamin B1 in Type 1 Diabetic Patients
NCT00117026
C-peptide Correlation With Microvascular Complications in T1DM
NCT04474535
Pathophysiology of Diabetic Gastroparesis
NCT05717205
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
EVOO-Butter
All patients and control subjects who met inclusion and exclusion criteria, and signed the Informed Consent, were scheduled for the two study visits, one week apart, during which each participant received two types of high GI meal: the first enriched with EVOO and the second with butter.
EVOO supplementation
We will administer to both groups (healthy and T1D subjects) a high glycemic index meal enriched with EVOO
Butter supplementation
We will administer to both groups (healthy and T1D subjects) a high glycemic index meal enriched with butter
Butter-EVOO
All patients and control subjects who met inclusion and exclusion criteria, and signed the Informed Consent, were scheduled for the two study visits, one week apart, during which each participant received two types of high GI meal: the first enriched with Butter and the second with EVOO
EVOO supplementation
We will administer to both groups (healthy and T1D subjects) a high glycemic index meal enriched with EVOO
Butter supplementation
We will administer to both groups (healthy and T1D subjects) a high glycemic index meal enriched with butter
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
EVOO supplementation
We will administer to both groups (healthy and T1D subjects) a high glycemic index meal enriched with EVOO
Butter supplementation
We will administer to both groups (healthy and T1D subjects) a high glycemic index meal enriched with butter
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* diagnosis of type 1 diabetes since at least 1 year,
* HbA1c \<8.5% (69 mmol/mol),
* stable insulin therapy for at least 3 months before the enrolment into the study
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Magna Graecia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Concetta Irace
Clinical Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Magna Graecia
Catanzaro, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Dietary Fat in Type 1 Diabetes
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.